Karimian-Jazi, K., Wildemann, B., Diem, R., Schwarz, D., Hielscher, T., Wick, W., . . . Breckwoldt, M. O. (2018). Gd contrast administration is dispensable in patients with MS without new T2 lesions on follow-up MRI. Neurology: Neuroimmunology & Neuroinflammation ; official journal of the American Academy of Neurology, 5(5), . https://doi.org/10.1212/NXI.0000000000000480
Chicago Style (17th ed.) CitationKarimian-Jazi, Kianush, Brigitte Wildemann, Ricarda Diem, Daniel Schwarz, Thomas Hielscher, Wolfgang Wick, Martin Bendszus, and Michael O. Breckwoldt. "Gd Contrast Administration Is Dispensable in Patients with MS Without New T2 Lesions on Follow-up MRI." Neurology: Neuroimmunology & Neuroinflammation ; Official Journal of the American Academy of Neurology 5, no. 5 (2018). https://doi.org/10.1212/NXI.0000000000000480.
MLA (9th ed.) CitationKarimian-Jazi, Kianush, et al. "Gd Contrast Administration Is Dispensable in Patients with MS Without New T2 Lesions on Follow-up MRI." Neurology: Neuroimmunology & Neuroinflammation ; Official Journal of the American Academy of Neurology, vol. 5, no. 5, 2018, https://doi.org/10.1212/NXI.0000000000000480.